Novo Nordisk A/S (NVO) Earnings History
Annual and quarterly earnings data from 1990 to 2025
Loading earnings history...
NVO EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NVO Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 81.0% | 41.4% | 33.1% |
| 2024 | 84.7% | 44.2% | 34.8% |
| 2023 | 84.6% | 44.2% | 36.0% |
| 2022 | 83.9% | 42.3% | 31.4% |
| 2021 | 83.2% | 41.7% | 33.9% |
Download Data
Export NVO earnings history in CSV or JSON format
Free sign-in required to download data
Novo Nordisk A/S (NVO) Earnings Overview
As of May 6, 2026, Novo Nordisk A/S (NVO) reported trailing twelve-month net income of $98.50B, reflecting +1.8% year-over-year growth. The company earned $22.15 per diluted share over the past four quarters, with a net profit margin of 33.1%.
Looking at the long-term picture, NVO's 5-year EPS compound annual growth rate (CAGR) stands at +20.6%, indicating exceptional earnings growth. The company achieved its highest annual net income of $100.99B in fiscal 2024.
Novo Nordisk A/S maintains industry-leading profitability with a gross margin of 81.0%, operating margin of 41.4%, and net margin of 33.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including LLY ($25.27B net income, 31.7% margin), SNY ($7.81B net income, 16.7% margin), AZN ($10.39B net income, 17.5% margin), NVO has outperformed on profitability metrics. Compare NVO vs LLY →
NVO Earnings vs Peers
Earnings metrics vs comparable public companies
NVO Historical Earnings Data (1990–2025)
36 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $98.50B | -2.5% | $123.04B | $23.03 | 33.1% | 41.4% |
| 2024 | $100.99B | +20.7% | $128.34B | $22.63 | 34.8% | 44.2% |
| 2023 | $83.68B | +50.7% | $102.57B | $18.62 | 36.0% | 44.2% |
| 2022 | $55.52B | +16.3% | $74.81B | $12.22 | 31.4% | 42.3% |
| 2021 | $47.76B | +13.3% | $58.64B | $10.37 | 33.9% | 41.7% |
| 2020 | $42.14B | +8.2% | $54.13B | $9.01 | 33.2% | 42.6% |
| 2019 | $38.95B | +0.8% | $52.48B | $8.19 | 31.9% | 43.0% |
| 2018 | $38.63B | +1.3% | $47.25B | $7.97 | 34.5% | 42.2% |
| 2017 | $38.13B | +0.5% | $48.97B | $7.70 | 34.1% | 43.8% |
| 2016 | $37.92B | +8.8% | $48.43B | $7.48 | 33.9% | 43.3% |
Full NVO Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Should I Buy NVO Right Now?
Bull case, key risks, Wall St analyst verdict, and what council investors are saying — updated daily.
See NVO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NVO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NVO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNVO — Frequently Asked Questions
Quick answers to the most common questions about buying NVO stock.
Is NVO growing earnings?
NVO EPS of $22.15 reflects slowing growth at +1.8%, below the 5-year CAGR of +20.6%. TTM net income is $98.5B. Expansion rate has moderated.
What are NVO's profit margins?
Novo Nordisk A/S net margin is +33.1%, with operating margin at +41.4%. Above-average margins indicate pricing power.
How consistent are NVO's earnings?
NVO earnings data spans 1990-2025. The current earnings trend is +1.8% YoY. Historical data enables comparison across business cycles.